Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabian Lang

Showing results (11-20 of 42) with videos related to

Pageof 5
Sort By:
Annals of Hematology|November 24, 2023
Liver failure after treatment with inotuzumab and polychemotherapy including PEG-asparaginase in a patient with relapsed Philadelphia chromosome-negative acute lymphoblastic leukemiaDaniel Fischer, Rosa Toenges, Kati Kiil, et al.
Annals of Hematology|April 9, 2016
Mismatched unrelated hematopoietic stem cell transplantation with post-transplant cyclophosphamide for high-risk acute myeloid leukemiaSarah Lindner, Tobias Berg, Julia Riemann, et al.
Frontiers in Immunology|December 3, 2024
GVHD after CAR T-cell therapy post allogeneic hematopoietic cell transplantation - successfully treated by extracorporeal photopheresisKiavasch Mohammad Nejad Farid, Gesine Bug, Anita Schmitt, et al.
Annals of Hematology|August 8, 2023
Treatment with midostaurin and other FLT3 targeting inhibitors is associated with an increased risk of cardiovascular adverse events in patients who underwent allogeneic hematopoietic stem cell transplantation with FLT3-mutated AMLAnjali Cremer, Julius C Enssle, Saskia Pfaff, et al.
Infection|December 19, 2024
Risk factors and outcome of Pseudomonas aeruginosa bloodstream infections (PABSI) in hematological patients: a single center retrospective cohort studyJohanna Kessel, Gesine Bug, Björn Steffen, et al.
Cancers|August 7, 2021
Tackling Tumour Cell Heterogeneity at the Super-Resolution Level in Human Colorectal Cancer TissueFabian Lang, María F Contreras-Gerenas, Márton Gelléri, et al.
Leukemia Research|August 5, 2021
Challenges of patients with myeloproliferative neoplasms (MPN) in times of COVID: First results from a patient survey by the German Study Group for MPNKim Kricheldorf, Konstanze Döhner, Frank Stegelmann, et al.
Bone Marrow Transplantation|April 21, 2022
Endothelial complications after allogeneic stem cell transplantation in patients with pretransplant resolved COVID-19Christian Niederwieser, Bodo Weber, Mirjam Reichard, et al.
BMC Pharmacology & Toxicology|September 30, 2020
A phase I study of a dual PI3-kinase/mTOR inhibitor BEZ235 in adult patients with relapsed or refractory acute leukemiaFabian Lang, Lydia Wunderle, Susanne Badura, et al.
Annals of Hematology|November 26, 2024
Central nervous system relapse after allogeneic HCT in FLT3-mutated AMLKhouloud Kouidri, Fabian Acker, Rosa Toenges, et al.
Pageof 5

Showing results (11-20 of 42) with videos related to

Sort By:
Pageof 5
Annals of Hematology|November 24, 2023
Liver failure after treatment with inotuzumab and polychemotherapy including PEG-asparaginase in a patient with relapsed Philadelphia chromosome-negative acute lymphoblastic leukemiaDaniel Fischer, Rosa Toenges, Kati Kiil, et al.
Annals of Hematology|April 9, 2016
Mismatched unrelated hematopoietic stem cell transplantation with post-transplant cyclophosphamide for high-risk acute myeloid leukemiaSarah Lindner, Tobias Berg, Julia Riemann, et al.
Frontiers in Immunology|December 3, 2024
GVHD after CAR T-cell therapy post allogeneic hematopoietic cell transplantation - successfully treated by extracorporeal photopheresisKiavasch Mohammad Nejad Farid, Gesine Bug, Anita Schmitt, et al.
Annals of Hematology|August 8, 2023
Treatment with midostaurin and other FLT3 targeting inhibitors is associated with an increased risk of cardiovascular adverse events in patients who underwent allogeneic hematopoietic stem cell transplantation with FLT3-mutated AMLAnjali Cremer, Julius C Enssle, Saskia Pfaff, et al.
Infection|December 19, 2024
Risk factors and outcome of Pseudomonas aeruginosa bloodstream infections (PABSI) in hematological patients: a single center retrospective cohort studyJohanna Kessel, Gesine Bug, Björn Steffen, et al.
Cancers|August 7, 2021
Tackling Tumour Cell Heterogeneity at the Super-Resolution Level in Human Colorectal Cancer TissueFabian Lang, María F Contreras-Gerenas, Márton Gelléri, et al.
Leukemia Research|August 5, 2021
Challenges of patients with myeloproliferative neoplasms (MPN) in times of COVID: First results from a patient survey by the German Study Group for MPNKim Kricheldorf, Konstanze Döhner, Frank Stegelmann, et al.
Bone Marrow Transplantation|April 21, 2022
Endothelial complications after allogeneic stem cell transplantation in patients with pretransplant resolved COVID-19Christian Niederwieser, Bodo Weber, Mirjam Reichard, et al.
BMC Pharmacology & Toxicology|September 30, 2020
A phase I study of a dual PI3-kinase/mTOR inhibitor BEZ235 in adult patients with relapsed or refractory acute leukemiaFabian Lang, Lydia Wunderle, Susanne Badura, et al.
Annals of Hematology|November 26, 2024
Central nervous system relapse after allogeneic HCT in FLT3-mutated AMLKhouloud Kouidri, Fabian Acker, Rosa Toenges, et al.
Pageof 5